 Bausch Lomb Corp. BLCO, -3.16 reported Wednesday first-quarter profit that topped expectations but revenue that came up short, as growth in vision care and surgical segment revenue was partially offset by declines in ophthalmic pharmaceuticals revenue. The contact lens and surgical device makers stock was still inactive in premarket trading. 